Machine Learning

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.

The lab automation firm is pivoting to intelligent systems, allowing scientists to create experiments with natural language to accelerate research.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

The deal combines Remsoft's analytics with INFLOR's forest management system, creating a powerful end-to-end platform for the global forestry value chain.

The new iGarden M1 Pro Max, a CES honoree, uses 3D vision to redefine pool cleaning, but it enters a crowded market of increasingly intelligent rivals.

Kelun-Biotech's sac-TMT gains its fourth approval in China, doubling survival time for patients with advanced HR+/HER2- breast cancer.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

With only 20% of Aussie SMEs insured against cyber threats, Cowbell and Zurich launch an AI-powered platform to simplify and expand coverage.

Ascentage Pharma's next-gen BTK degrader, APG-3288, receives dual IND clearance, paving the way for clinical trials to fight resistant blood cancers.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

The move signals a major validation for AI in enterprise workforce strategy, as the former J&J CHRO lends his expertise to the growing tech firm.

In a strategic move to combat rising mobile threats, Guardsquare acquires Verimatrix's XTD, creating a new end-to-end security powerhouse.

A new partnership aims to revolutionize sleep and allergy treatment with FDA-cleared, AI-personalized wearables, moving beyond tracking to active intervention.

A top engineering prize honors John Donoghue for BrainGate, a technology that lets the mind control machines, offering new hope for paralysis and ALS.

Kovr.ai and Knox Systems just did the impossible, securing federal authorization in six weeks. Here's how their AI-powered model is rewriting the rules.